Title

close iconicon dots

T1D Guide

T1D Strong News

Personal Stories

Resources

T1D Misdiagnosis

T1D Early Detection

Research/Clinical Trials

When Insurance Dictates Diabetes Technology: Dexcom G7 Users Face a Forced Switch

If you have CVS Caremark or Aetna as your insurance provider, you may have received a notification that some plans will no longer cover the Dexcom Continuous Glucose Monitor (CGM) as a pharmacy benefit. As of January 1, 2027, certain Dexcom users will need to switch to Abbott’s FreeStyle Libre 3 Plus.

When Insurance Dictates Diabetes Technology: Dexcom G7 Users Face a Forced Switch

Dexcom G7 and Abbott FreeStyle Libre 3 Plus are both capable continuous glucose monitors. Both were named in T1D Strong’s 6 Best Continuous Glucose Monitors of 2026.

However, the impact of insurance-mandated CGM switching on people living with type 1 diabetes (T1D) is not simply about which glucose monitor is better – it’s about choice.

For someone who has spent months or years learning to manage diabetes with one device, being told to switch because of an insurance formulary decision can be disruptive, frustrating, and potentially consequential.

This is an important distinction.

Who Gets to Choose?

The issue is not switching to an equally adequate CGM. The fact that patients have little say in which CGM their insurance covers is disturbing. We know with diabetes, there’s no one-size-fits-all. Two people can have different pump settings; they can react differently to certain carbs and exercise, and they respond differently to certain insulin pumps and CGMs. Some have allergic skin reactions; others require customized notifications. Compatibility is key with automated insulin delivery (AID) systems. A device that works well for one person may not work as well for another.

Also, switching devices can be problematic and time-consuming. You’ll need to learn new technology, fill new prescriptions, order new supplies, complete additional training, troubleshoot, and share data with caregivers and healthcare providers.

Read on to understand how this change may affect your coverage, what you can do now, and, if forced, how to make the transition as smooth as possible.

A New CGM Requires a Big Learning Curve

A CGM is not just another medical supply. It becomes part of a person’s daily diabetes-management routine. Patients and caregivers become accustomed to:

  • How glucose readings appear and how quickly they update.
  • How alerts are delivered and customized.
  • How glucose data are shared with parents, spouses, and caregivers.
  • How the device works with their insulin pump and automated insulin delivery (AID) system.
  • Sensor placement, adhesive performance, and comfort.

DPAC’s Campaign and Position

Undoubtedly, this creates stress and anxiety for people with diabetes and their families, which is why the Diabetes Patient Advocacy Coalition (DPAC) launched an advocacy letter-writing campaign in response to CVS Caremark and Aetna’s decision to drop Dexcom in favor of the Abbott FreeStyle Libre.

DPAC’s online action campaign lets patients, caregivers, and advocates send letters directly to CVS Caremark and Aetna urging them to halt forced non-medical switches and protect uninterrupted access to CGM technology.

Criticism of Monopolies

DPAC and community advocates have highlighted how decisions by certain healthcare entities (a pharmacy benefit manager (PBM), insurer, and pharmacy network) dictating device choices may harm diabetes management by ignoring that CGM systems are not interchangeable.

Steps to Take with DPAC

  • First, check your specific insurance plan. Not everyone is affected. Coverage changes vary by employer, insurance plan, and benefit design. Visit here to learn more.
  • Work with prescribers to explore medical-necessity exceptions, durable medical equipment (DME) channels, or alternative coverage paths.
  • Participate in the DPAC Letter Campaign to cite what a forced CGM switch could mean for you.

Steps to Ensure a Smooth Transition to New CGM:

  1. Contact your doctor to let them know about the changes to your covered device. If your prescriber agrees to the change, they can send a new prescription to your pharmacy so it’s ready to fill starting January 1, 2027.
  2. This change will help you avoid paying the full cost.
  3. Keep in mind, if you refill the prescription for your current device after January 1, 2027, you’ll need to pay the full cost.

What Dexcom G7 Users Need to Know for 2027

If you are switching from Dexcom G6 or G7 to Abbott’s FreeStyle Libre 3 Plus, note that both are advanced continuous glucose monitors that provide real-time glucose readings, track trends, and alert you to high and low glucose readings.

However, there are some meaningful differences in sensor life, data frequency, warm-up time, connectivity, and pump compatibility.

Dexcom G7 vs. Abbott FreeStyle Libre 3 Plus

The Libre 3 Plus is a strong competitor to the Dexcom G7, particularly in sensor longevity, size, reading frequency, and insulin pump compatibility. Dexcom retains meaningful advantages in predictive low alerts, warm-up time, and connectivity.

Important Differences to Consider

Sensor Wear Time

Some Dexcom sensors last 10 days vs. Libre 15 days.

Glucose Reading Frequency

  • Dexcom G7: Transmits glucose readings every five minutes.
  • Libre 3 Plus: Transmits glucose readings every minute.

Warm-up Time

Dexcom’s advantage here is that the G7 gets users back to receiving glucose readings sooner after inserting a new sensor.

  • Dexcom G7: 30 minutes.
  • Libre 3 Plus: 60 minutes.

Alerts and Alarms

Both systems offer customizable high- and low-glucose alerts, along with notifications for signal loss. However, Dexcom has an additional feature worth highlighting:

Urgent Low Soon: The G7 can predict when glucose is likely to fall below 55 mg/dL within about 20 minutes, giving users time to respond before reaching that level.

Accuracy

Accuracy is one of the most important considerations when choosing a CGM.

A commonly used measure is MARD (Mean Absolute Relative Difference). Generally, a lower MARD score is better, indicating a closer agreement between CGM readings and reference glucose measurements.

Dexcom G7: Adult MARD is 8.2%, and the pediatric MARD is 8.1%. For young children (ages 2-5): 7.7%

Libre 3 Plus: Adult MARD is 8.2%, and the pediatric MARD is 8.2%. For young children (ages 2-5): 9.7%

Insulin Pump Compatibility

Both Dexcom G7 and FreeStyle Libre 3 Plus integrate with select automated insulin delivery systems, but compatibility varies by pump. For people who rely on a specific CGM-pump combination, an insurance-mandated switch could affect their existing diabetes-management technology. Patients should verify compatibility before changing devices.

The Libre 3 Plus sensor now connects with all leading U.S. insulin pump brands. Current compatible automated insulin delivery systems include Insulet Omnipod 5, Tandem t:slim X2, Beta Bionics’ iLet Bionic Pancreas and twiist. Notably, Tandem has communicated that Mobi compatibility with the Libre 3 Plus sensor is expected to be commercially available in the U.S. by the first half of 2027.  

Important Note: On August 25, 2026, Abbott received FDA authorization and CE Mark approval for the world's first dual glucose-ketone sensing technology for people with diabetes. The Libre 10-Day DUO is a first-of-its-kind, two-in-one bio-wearable that continuously monitors glucose and helps detect rising ketone levels, which can lead to diabetic ketoacidosis (DKA), a serious and potentially life-threatening complication. The device is approved for individuals aged 2 years and older.

Advantages and Disadvantages

Dexcom G7

Strengths

  • Faster 30-minute warm-up.
  • Predictive Urgent Low Soon alert.
  • Three simultaneous Bluetooth connections.
  • Direct Apple Watch connectivity.
  • Established integration with multiple insulin pumps.

Limitations

  • Glucose readings every five minutes.
  • Requires an overpatch.
  • More frequent sensor replacements.

Abbott FreeStyle Libre 3 Plus

Strengths

  • Glucose readings every minute.
  • Smaller, thinner sensor.
  • No overpatch required.
  • Broad automated insulin delivery compatibility.
  • 15 days of sensor memory.

Limitations

  • Longer 60-minute warm-up.
  • No equivalent predictive Urgent Low Soon alert.
  • Shorter water-immersion rating.
  • One simultaneous Bluetooth connection.

Remote Glucose Sharing

Both Dexcom G7 and FreeStyle Libre 3 Plus offer remote glucose sharing, which is especially important for parents, spouses, and caregivers of people with T1D. The two systems offer similar core functionality, but Dexcom Follow has some advantages in flexibility for individual follower notification preferences while the LibreLinkUp allows for more followers.

Number of people who can follow glucose readings

  • Dexcom Follow: Up to 10 people can follow one person's glucose readings.
  • LibreLinkUp: Up to 20 people can follow one person's glucose readings.

Customizable alerts

Both apps allow caregivers to receive notifications about high and low glucose levels.

  • Dexcom Follow: Followers can customize their own notification settings, including glucose thresholds and notification preferences.
  • LibreLinkUp: Caregivers receive glucose alarms enabled by the person using the Libre system. Available notifications depend on the settings in the primary Libre app.

Dexcom’s Response to Upcoming Insurance Changes

Dexcom executives addressed the upcoming CVS Caremark and Aetna formulary changes during the company’s October 29, 2026, third-quarter earnings call, emphasizing that “CGM systems are not necessarily interchangeable for every person with diabetes.” CEO Jake Leach highlighted the potential consequences for patients who rely on Dexcom’s integration with automated insulin delivery systems, caregiver data sharing through Share/Follow, and other device-specific features.

Leach cited the company’s position that insurers should provide equal access to competing CGM technologies rather than restrict patients to a single manufacturer. Dexcom says it is working to help affected customers navigate alternative coverage options and plans to introduce Dexcom Direct in early 2027 to provide additional assistance.

Overall Takeaway

Decisions about diabetes technology should prioritize patients, not simply insurance costs. First and foremost, let your voice be heard. Take action with DPAC, and let your insurance provider know how you feel about this forced change. People living with diabetes should have a meaningful voice in choosing the technology they rely on to manage their condition. Insurance formulary changes should not disrupt established treatment routines or compromise access to devices that best meet individual medical needs.

Secondly, make sure your prescriptions are in place for you or your loved ones, so there is no gap in coverage. Educate yourself on your new CGM and sensor.

Individuals with diabetes face a constant stream of challenges that require routines and discipline. All of which foster high levels of daily problem solving and perseverance. Building resilience is one of the strengths of T1Ds and their caregivers. Still, you don't have to face every obstacle alone. Connect with healthcare providers, support groups and mental health resources.

Latest News

Read all
arrow
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
T1D Strong DNA test has been awarded at ADA 2024 conference

Our DNA test is selected as one of the finalists for the American Diabetes Association Innovation Challenge 2024!

T1D Team

T1D Team

T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Achieving the Milestone - 100 Articles Published!

We're just getting started! Committed to empowering the T1D community, we continue to share knowledge and stories.

T1D Team

T1D Team

Read all
arrow

Related Articles

The latest news, technologies, and resources from our team.

“I Thought I Could Reverse Type 1”: Making Friends With a Chronic Condition in India
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
“I Thought I Could Reverse Type 1”: Making Friends With a Chronic Condition in India
Preparing for Emergencies with Type 1 Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Preparing for Emergencies with Type 1 Diabetes
I Don’t Like My Doctor. Now What? Finding the Right Endocrinologist for Type 1 Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
I Don’t Like My Doctor. Now What? Finding the Right Endocrinologist for Type 1 Diabetes
Seraxis and Sernova Proposed Merger Targets a New Era of Type 1 Diabetes Treatment
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Seraxis and Sernova Proposed Merger Targets a New Era of Type 1 Diabetes Treatment
Health Insurance Open Enrollment: How to Choose a Plan with Type 1 Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Health Insurance Open Enrollment: How to Choose a Plan with Type 1 Diabetes
Why Adults Living with Type 1 Diabetes Across the U.S. Are Building Their Own Communities
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Why Adults Living with Type 1 Diabetes Across the U.S. Are Building Their Own Communities
T1D to the Third Uplifts Youths through Virtual Community Engagement
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
T1D to the Third Uplifts Youths through Virtual Community Engagement
How JDCA is Bringing Transparency to Type 1 Diabetes Cure Research
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
How JDCA is Bringing Transparency to Type 1 Diabetes Cure Research
The New Global Type 1 Diabetes Screening Schedule: A Major Shift in Early Detection
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
The New Global Type 1 Diabetes Screening Schedule: A Major Shift in Early Detection
Type 1 Diabetes and Kidney Health: What You Need to Know to Protect Them
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Type 1 Diabetes and Kidney Health: What You Need to Know to Protect Them
Sana’s Gene-Edited Islet Cells Are Still Producing Insulin After 14 Months—Without Immunosuppression
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Sana’s Gene-Edited Islet Cells Are Still Producing Insulin After 14 Months—Without Immunosuppression
The Money Behind a Diabetes Cure: How Investors Could Profit from T1D Research
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
The Money Behind a Diabetes Cure: How Investors Could Profit from T1D Research
More Than a Better Glucose Tablet: How Friendship and Lived Experience Shaped ZAP Glucose
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
More Than a Better Glucose Tablet: How Friendship and Lived Experience Shaped ZAP Glucose
ChatGPT Helps Uncover Type 1 Diabetes Following a Type 2 Misdiagnosis
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
ChatGPT Helps Uncover Type 1 Diabetes Following a Type 2 Misdiagnosis
UK Children’s Author Tim Manning Creates Diabuddies to Help Children with T1D
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
UK Children’s Author Tim Manning Creates Diabuddies to Help Children with T1D
EDENT1FI’s T1D Screening Research Lands Top ADA 2026 Honor
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
EDENT1FI’s T1D Screening Research Lands Top ADA 2026 Honor
New UK Study Aims to Understand Diabetes Burnout Better
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
New UK Study Aims to Understand Diabetes Burnout Better
Misdiagnosed as Type 2 Diabetes: When No One Listens in Type 1 Diabetes Care
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Misdiagnosed as Type 2 Diabetes: When No One Listens in Type 1 Diabetes Care
Panel of CEOs Discusses the Hidden Burden of Diabetes: the Mental Load
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Panel of CEOs Discusses the Hidden Burden of Diabetes: the Mental Load
India’s Rising Type 1 Diabetes Crisis: Why Cases Are Surging and What It Means
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
India’s Rising Type 1 Diabetes Crisis: Why Cases Are Surging and What It Means
Father and Son Paul and Nick Peloso Discuss Growing Up with Type 1 Diabetes and the Breakthrough T1D Therapy Paul Is Developing
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Father and Son Paul and Nick Peloso Discuss Growing Up with Type 1 Diabetes and the Breakthrough T1D Therapy Paul Is Developing
Aging with Type 1 Diabetes: Joanne Milo on Research Gaps and Systems Reform
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Aging with Type 1 Diabetes: Joanne Milo on Research Gaps and Systems Reform
Highlights, Controversy, and Celebration at the ADA’s 86th Scientific Sessions
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Highlights, Controversy, and Celebration at the ADA’s 86th Scientific Sessions
How Searching For Answers Changed One Man’s T1D Journey
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
How Searching For Answers Changed One Man’s T1D Journey
World’s Largest Diabetes Camp Offers T1D Campers a Life-Changing Experience
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
World’s Largest Diabetes Camp Offers T1D Campers a Life-Changing Experience
Beyond the Arrows: How Families Can Reduce Overreaction and Anxiety Around Diabetes Data
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Beyond the Arrows: How Families Can Reduce Overreaction and Anxiety Around Diabetes Data
Does Type 1 Diabetes Kill Your Sex Drive?
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Does Type 1 Diabetes Kill Your Sex Drive?
SCREEN for T1D Act Reintroduced into Congress
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
SCREEN for T1D Act Reintroduced into Congress
Award-Winning Author of Type One Determination, Lauren Plunkett, on Finding Self-Worth and Leading a Healthy, Athletic Life
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Award-Winning Author of Type One Determination, Lauren Plunkett, on Finding Self-Worth and Leading a Healthy, Athletic Life
The Dexcom G8 Breakthrough: Why Everyone Is Talking About It
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
The Dexcom G8 Breakthrough: Why Everyone Is Talking About It
How Stash Diabetes is Simplifying Type 1 Supply Tracking, with Founder Cory Zapatka
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
How Stash Diabetes is Simplifying Type 1 Supply Tracking, with Founder Cory Zapatka
Why Type 1 Diabetes Screening Still Overlooks Adults
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Why Type 1 Diabetes Screening Still Overlooks Adults
The Place to Learn about Diabetes Research
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
The Place to Learn about Diabetes Research
The Risks of Renaming Type 1 Diabetes and Why It Could Do More Harm Than Good
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
The Risks of Renaming Type 1 Diabetes and Why It Could Do More Harm Than Good
The Weight and Wonder of Motherhood with Type 1 Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
The Weight and Wonder of Motherhood with Type 1 Diabetes
Sarah Picklo Halabu: Telehealth Leader and Founder of Hello Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Sarah Picklo Halabu: Telehealth Leader and Founder of Hello Diabetes
Tzield Just Approved for Ages 1 and Up in Stage 2 T1D
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Tzield Just Approved for Ages 1 and Up in Stage 2 T1D
ATTD: Advancing Diabetes Innovation in Barcelona
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
ATTD: Advancing Diabetes Innovation in Barcelona
Type 1 Diabetes Breakthroughs to Watch in 2026
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Type 1 Diabetes Breakthroughs to Watch in 2026
Best Insulin Pumps for Type 1 Diabetes in 2026 (Top 6 Compared)
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Best Insulin Pumps for Type 1 Diabetes in 2026 (Top 6 Compared)
Early Detection of Type 1 Diabetes: Mom Uses T1D Scout to Screen Her Children at Home
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Early Detection of Type 1 Diabetes: Mom Uses T1D Scout to Screen Her Children at Home
Dr. William Polonsky and the Behavioral Diabetes Institute on Diabetes Distress and Mental Health in Diabetes Care
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Dr. William Polonsky and the Behavioral Diabetes Institute on Diabetes Distress and Mental Health in Diabetes Care
 Low-Carb Living with Diabetes: Nupur Lalvani’s Journey to Clearer Numbers and Peace of Mind
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Low-Carb Living with Diabetes: Nupur Lalvani’s Journey to Clearer Numbers and Peace of Mind
Best Type 1 Diabetes Apps of 2026: Top 10 for CGM, Insulin & Tracking
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Best Type 1 Diabetes Apps of 2026: Top 10 for CGM, Insulin & Tracking
Digital Diabetes Nutrition Counseling Improves A1C, Led by Women Dietitians
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Digital Diabetes Nutrition Counseling Improves A1C, Led by Women Dietitians
Why the ISLET Cell Act Matters Now for People With Type 1 Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Why the ISLET Cell Act Matters Now for People With Type 1 Diabetes
Scared to Screen for Type 1 Diabetes? 5 Reasons Parents and Those with Higher Risk Shouldn’t Wait
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Scared to Screen for Type 1 Diabetes? 5 Reasons Parents and Those with Higher Risk Shouldn’t Wait
A Conference that Bridges the Gap Between Diabetes and Mental Health
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
A Conference that Bridges the Gap Between Diabetes and Mental Health
IDF‑ISPAD Policy Brief: Detecting Type 1 Diabetes Early
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
IDF‑ISPAD Policy Brief: Detecting Type 1 Diabetes Early
6 Best Continuous Glucose Monitors for 2026: Most Accurate and Latest Devices Reviewed
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
6 Best Continuous Glucose Monitors for 2026: Most Accurate and Latest Devices Reviewed
Ketones Crash Course: 3 Things Every T1D Needs to Know
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Ketones Crash Course: 3 Things Every T1D Needs to Know
Making History: Black T1D Advocates Redefining Diabetes Awareness
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Making History: Black T1D Advocates Redefining Diabetes Awareness
Can AI Help You Manage Diabetes? What It Can and Can’t Do
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Can AI Help You Manage Diabetes? What It Can and Can’t Do
When Diabetes Devices Fail: What to Do When an Insulin Pump or CGM Stops Working
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
When Diabetes Devices Fail: What to Do When an Insulin Pump or CGM Stops Working
Type 1 Diabetes: The Invisible Job No One Pays You For
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Type 1 Diabetes: The Invisible Job No One Pays You For
Streamlining Type 1 Diabetes Education with animaT1D
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Streamlining Type 1 Diabetes Education with animaT1D
Type 1 Diabetes and Career Choices: What to Know Before You Decide
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Type 1 Diabetes and Career Choices: What to Know Before You Decide
Free FDA-Cleared Insulin Calculator for Type 1 Diabetes—Built by a 13-Year-Old
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Free FDA-Cleared Insulin Calculator for Type 1 Diabetes—Built by a 13-Year-Old
A New Era in Type 1 Diabetes Safety: Continuous Ketone Monitoring
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
A New Era in Type 1 Diabetes Safety: Continuous Ketone Monitoring
Type 1 Diabetes in 2025: Advances in Early Detection, Screening, and What’s Next
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Type 1 Diabetes in 2025: Advances in Early Detection, Screening, and What’s Next
7 Tips to Maximize Savings this Year for Insulin and Diabetes Supplies
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
7 Tips to Maximize Savings this Year for Insulin and Diabetes Supplies
Why Hospitals and Doctors’ Offices are Still Unprepared for Type 1 Diabetes Care
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Why Hospitals and Doctors’ Offices are Still Unprepared for Type 1 Diabetes Care
8 Soulful Tips to Live a Happier, More Mindful Life with T1D
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
8 Soulful Tips to Live a Happier, More Mindful Life with T1D
Aging With Type 1 Diabetes: Long-Term Care, Cognitive Changes and Who Will Care for Us
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Aging With Type 1 Diabetes: Long-Term Care, Cognitive Changes and Who Will Care for Us
ADA Standards of Care 2026 Highlights for Type 1 Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
ADA Standards of Care 2026 Highlights for Type 1 Diabetes
Grownup T1Ds Expands Nationwide For Adults Living With Type 1 Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Grownup T1Ds Expands Nationwide For Adults Living With Type 1 Diabetes
13 Best Type 1 Diabetes Children’s Books for Holiday Gifting
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
13 Best Type 1 Diabetes Children’s Books for Holiday Gifting
Type 1 Diabetes Advocacy: From Lived Experience To Legislation on Capitol Hill
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Type 1 Diabetes Advocacy: From Lived Experience To Legislation on Capitol Hill
Type 1 Diabetes: The Hidden Blood Sugar Impact of Holiday Foods
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Type 1 Diabetes: The Hidden Blood Sugar Impact of Holiday Foods
Diabetech Founder Justin Eastzer Simplifies Diabetes Technology with Humor and Heart
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Diabetech Founder Justin Eastzer Simplifies Diabetes Technology with Humor and Heart
Diversity in Diabetes: Supporting Every Person Living with Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Diversity in Diabetes: Supporting Every Person Living with Diabetes
The Hidden Consequences of Being Misdiagnosed with Type 1 Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
The Hidden Consequences of Being Misdiagnosed with Type 1 Diabetes
Diabetes and Hearing Loss: The Invisible Condition No One Talks About
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Diabetes and Hearing Loss: The Invisible Condition No One Talks About
Eric Moyal’s Project Insulin Seeks to Solve the Insulin Cost Crisis
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Eric Moyal’s Project Insulin Seeks to Solve the Insulin Cost Crisis
Halloween with Type 1 Diabetes: A Parent’s Guide to Trick-or-Treating
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Halloween with Type 1 Diabetes: A Parent’s Guide to Trick-or-Treating
FDA Fast-Tracks Tzield for Stage 3 Type 1 Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
FDA Fast-Tracks Tzield for Stage 3 Type 1 Diabetes
Diabetes and Air Travel: How TSA Cares Helps You Navigate Airport Security
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Diabetes and Air Travel: How TSA Cares Helps You Navigate Airport Security
Affordable Insulin: Sanofi Caps Monthly Cost at $35 for All U.S. Patients
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Affordable Insulin: Sanofi Caps Monthly Cost at $35 for All U.S. Patients
Food Noise, Diabetes, and GLP-1s like Ozempic
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Food Noise, Diabetes, and GLP-1s like Ozempic
What Causes Type 1 Diabetes: Your Beta Cells or Immune System?
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
What Causes Type 1 Diabetes: Your Beta Cells or Immune System?
Happy Bob App: Diabetes Management With Humor and Gamification
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Happy Bob App: Diabetes Management With Humor and Gamification
Doctors at UI Health Performed the First Islet Transplant with Lantidra
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Doctors at UI Health Performed the First Islet Transplant with Lantidra
Top Type 1 Diabetes Research Breakthroughs to Watch in 2025
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Top Type 1 Diabetes Research Breakthroughs to Watch in 2025
Touched by Type 1 Dazzles with Expression and Meaningful Resources
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Touched by Type 1 Dazzles with Expression and Meaningful Resources
Choosing the Best Diabetes Devices: How DiabetesWise Leads the Charge
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Choosing the Best Diabetes Devices: How DiabetesWise Leads the Charge
Revolutionizing Type 1 Diabetes Care: Dr. Monica Gomberg and Blue Circle Health
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Revolutionizing Type 1 Diabetes Care: Dr. Monica Gomberg and Blue Circle Health
Insulin Shortages: How to Stay Informed and Protected
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Insulin Shortages: How to Stay Informed and Protected
Type 1 Diabetes and Weight Loss: Why Goals Must Come From a Place of Love
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Type 1 Diabetes and Weight Loss: Why Goals Must Come From a Place of Love
Diabetes Research Connection Launches 2025 Funding Opportunities for Early-Career Type 1 Diabetes Scientists
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Diabetes Research Connection Launches 2025 Funding Opportunities for Early-Career Type 1 Diabetes Scientists
From Diagnosis to Advocacy: Delivering Medical IDs to Children With Type 1 Diabetes
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
From Diagnosis to Advocacy: Delivering Medical IDs to Children With Type 1 Diabetes
Global Summit Aims to End Diabetes Stigma: Be Part of the Movement
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Global Summit Aims to End Diabetes Stigma: Be Part of the Movement
New Type 1 Diabetes Trial Using Pig Islets
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
New Type 1 Diabetes Trial Using Pig Islets
T1D Sibling Screening: A Parent’s Guide to Why It’s Critical and Easy
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
T1D Sibling Screening: A Parent’s Guide to Why It’s Critical and Easy
Abbott's Biowearable: One Sensor for Glucose and Ketones
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Abbott's Biowearable: One Sensor for Glucose and Ketones
The Dangers of Sunburn with Diabetes: How to Get Ahead of the Heat
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
The Dangers of Sunburn with Diabetes: How to Get Ahead of the Heat
Back-to-School Guide for T1D Parents: Tips & Checklist
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Back-to-School Guide for T1D Parents: Tips & Checklist
Prepare for Pregnancy with Type 1 Diabetes with These Tips
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Prepare for Pregnancy with Type 1 Diabetes with These Tips
Are Over-the-Counter CGMs Good for All?
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Are Over-the-Counter CGMs Good for All?
Here’s How the One Big Beautiful Bill May Impact People with T1D
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Here’s How the One Big Beautiful Bill May Impact People with T1D
Diabetes and Oral Health: What You Need to Know
T1D GuideT1D Strong NewsPersonal StoriesResourcesT1D MisdiagnosisT1D Early DetectionResearch/Clinical Trials
Diabetes and Oral Health: What You Need to Know
Load More
background image

Knowledge Base

Personal Stories

Life stories of relentless individuals fostering resilience and empowering others.

Learn more

arrow

T1D Strong News

Stay updated with the latest from T1D Strong: product updates, company events, notable achievements and our future plans.

Learn more

arrow

T1D Early Detection

Discover advanced screening methods for early T1D detection. Learn about breakthrough diagnostics and early signs for proactive management.

Learn more

arrow

Research/Clinical Trials

Explore the latest breakthroughs in clinical research and trials. Stay informed about innovative treatments and scientific discoveries shaping the future of medicine.

Learn more

arrow

T1D Misdiagnosis

Understanding common queries and exclusive information about diabetes of any type.

Learn more

arrow

T1D Guide

Strategies to enhance lifestyle optimization with type 1 diabetes.

Learn more

arrow

Resources

Knowledge hub for advanced information on type 1 diabetes.

Learn more

arrow